MEGAN FERNANDEZ: Open Payments
NPI 1285155028 · CROSS LANES, WV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 117 payments from 19 companies in 2025. Trend: 2023 $896 · 2024 $1,066 · 2025 $1,584
Food & beverage: $1,560Education: $24
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 25 | $310 |
| ABBVIE INC. | 19 | $208 |
| Amgen Inc. | 21 | $186 |
| AstraZeneca Pharmaceuticals LP | 8 | $174 |
| Sumitomo Pharma America, Inc. | 14 | $166 |
| Exact Sciences Corporation | 5 | $99 |
| PFIZER INC. | 3 | $65 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $58 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $52 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $50 |
Products named: Ozempic, GEMTESA, OTEZLA, VRAYLAR, Cologuard Collection Kit, AIRSUPRA, PREVNAR 20, XIFAXAN.
Industry payments across WV — which companies pay providers there.
